期刊文献+

血管内皮抑制素的研究进展 被引量:6

Advances in endostatin research
暂未订购
导出
摘要 Endostatin, a 20 kD (184 aa) C-teminal fragment of collagenⅩⅧ,is the most potent inhibitor of tumor angiogenesis described so for. Endostatin was initially isolated from a murine hemangioendothelioma cell line (EOMA). Purified recombinant murine endostatin generated in E.coli bacteria injected as unfolded suspension, inhibited the growth of a varity of metastatic and primary tumors in mice. However, its widespread application has been hampered by difficulties in the large-scale production of the antiangiogenic proteins. The limitation may be resolved by in vivo delivery and expression of the antitangiogenic gene. This review summarized the advances in endostain research in recent years including structure, the mechanism of generating ,function and therapy. Endostatin, a 20 kD (184 aa) C-teminal fragment of collagenⅩⅧ,is the most potent inhibitor of tumor angiogenesis described so for. Endostatin was initially isolated from a murine hemangioendothelioma cell line (EOMA). Purified recombinant murine endostatin generated in E.coli bacteria injected as unfolded suspension, inhibited the growth of a varity of metastatic and primary tumors in mice. However, its widespread application has been hampered by difficulties in the large-scale production of the antiangiogenic proteins. The limitation may be resolved by in vivo delivery and expression of the antitangiogenic gene. This review summarized the advances in endostain research in recent years including structure, the mechanism of generating ,function and therapy.
作者 岳滔 朱振宇
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2002年第7期865-868,共4页 Chinese Journal of Pathophysiology
基金 国家教育部留学归国人员启动基金资助
关键词 血管内皮抑制素 研究进展 肿瘤 抗血管生成 药理学 Neoplasms Endostatin Anti-angiogenesis
  • 相关文献

参考文献28

  • 1[1]Folkman J. Tumor angiogenesis: therapeutic implication [J].New Engl J Med, 1971, 285(21): 1182- 1186.
  • 2[2]Folkman J. Anti- angiogenesis: new concept for therapy ofsolid tumors [J]. Ann Surg, 1972,175(3): 409-416.
  • 3[3]O'Relly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth [ J].Cell, 1997, 88(2): 277-285.
  • 4[4]Standker L, Schrader M, Kanse SM, et al. Isolation andcharacterization of the circulating form of human endostatin[J]. FEBS Lett, 1997, 420(2- 3): 129- 133.
  • 5[5]Ding YH, Kashi Javaherian, Kin- MingLo,et al. Zinc- dependent dimers observed in crystals of human endostain [ J ].Proc Natl Acad Sci USA, 1998,95(18): 10443- 10448.
  • 6[6]HohenesterE, SasakiT, OlsenBR, etal. Crystal structure ofthe angiogenesis inhibitor endostatin at 1.5 A resolution [J].Embo J, 1998,17(6): 1656 - 1664 .
  • 7[7]Sasaki T, Fukai N, Mann K, et al. Structure ,function andtissue forms of the globular domain of the C- terminal globulardomain of collagen X Ⅷ containing the angiogenesis inhibitorendostatin[J]. Embo J, 1998,17(15) :4249 - 4256.
  • 8[8]Yamaguchi N, Anand AB, Lee M, et al. Endostatin inhibitsVEGF- induced endothelial cell migration and tumor growthindependently of zinc binding [J]. EMBO J, 1999,18(16):4414 - 4423.
  • 9[9]Hohenester E, Sasaki T, Mann K, et al. Variable zinc coordination in endostatin[J], J Mol Biol, 2000,297(1): 1- 6.
  • 10[10]Schuppan D, Cramer T, Bauer M, et al. Hepatocytes as asource of collagen type X Ⅷ endostatin[J]. Lancet, 1998,352(9131): 879- 880.

同被引文献67

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部